ArticleFrontiers in oncology2021

Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab.

Michael Pogorzelski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.